Request for Covid-19 Impact Assessment of this Report
The United States Seasonal Influenza Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Seasonal Influenza Vaccines market, reaching US$ million by the year 2028. As for the Europe Seasonal Influenza Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Seasonal Influenza Vaccines players cover GlaxoSmithKline plc, Sinovac Biotech Ltd, Changsheng Bio-Technology, and Ccbio SA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Seasonal Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Type A (H1N1)
Type A (H3N2)
Type B
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pediatrics
Adolescence
Adults
Elderly
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline plc
Sinovac Biotech Ltd
Changsheng Bio-Technology
Ccbio SA
Aleph Biomedical
Sanofi
Jiangsu Simcere Vaxtec Bio-pharmaceutical
Dalian Hissen Bio-pharm
Abbott Laboratories
Novartis International AG
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Seasonal Influenza Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Seasonal Influenza Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Seasonal Influenza Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Seasonal Influenza Vaccines Segment by Type
2.2.1 Type A (H1N1)
2.2.2 Type A (H3N2)
2.2.3 Type B
2.3 Seasonal Influenza Vaccines Sales by Type
2.3.1 Global Seasonal Influenza Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Seasonal Influenza Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Seasonal Influenza Vaccines Sale Price by Type (2017-2022)
2.4 Seasonal Influenza Vaccines Segment by Application
2.4.1 Pediatrics
2.4.2 Adolescence
2.4.3 Adults
2.4.4 Elderly
2.5 Seasonal Influenza Vaccines Sales by Application
2.5.1 Global Seasonal Influenza Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Seasonal Influenza Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Seasonal Influenza Vaccines Sale Price by Application (2017-2022)
3 Global Seasonal Influenza Vaccines by Company
3.1 Global Seasonal Influenza Vaccines Breakdown Data by Company
3.1.1 Global Seasonal Influenza Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Seasonal Influenza Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Seasonal Influenza Vaccines Revenue by Company (2020-2022)
3.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Seasonal Influenza Vaccines Sale Price by Company
3.4 Key Manufacturers Seasonal Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Seasonal Influenza Vaccines Product Location Distribution
3.4.2 Players Seasonal Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Seasonal Influenza Vaccines by Geographic Region
4.1 World Historic Seasonal Influenza Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Seasonal Influenza Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Seasonal Influenza Vaccines Annual Revenue by Geographic Region
4.2 World Historic Seasonal Influenza Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Seasonal Influenza Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Seasonal Influenza Vaccines Annual Revenue by Country/Region
4.3 Americas Seasonal Influenza Vaccines Sales Growth
4.4 APAC Seasonal Influenza Vaccines Sales Growth
4.5 Europe Seasonal Influenza Vaccines Sales Growth
4.6 Middle East & Africa Seasonal Influenza Vaccines Sales Growth
5 Americas
5.1 Americas Seasonal Influenza Vaccines Sales by Country
5.1.1 Americas Seasonal Influenza Vaccines Sales by Country (2017-2022)
5.1.2 Americas Seasonal Influenza Vaccines Revenue by Country (2017-2022)
5.2 Americas Seasonal Influenza Vaccines Sales by Type
5.3 Americas Seasonal Influenza Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Seasonal Influenza Vaccines Sales by Region
6.1.1 APAC Seasonal Influenza Vaccines Sales by Region (2017-2022)
6.1.2 APAC Seasonal Influenza Vaccines Revenue by Region (2017-2022)
6.2 APAC Seasonal Influenza Vaccines Sales by Type
6.3 APAC Seasonal Influenza Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Seasonal Influenza Vaccines by Country
7.1.1 Europe Seasonal Influenza Vaccines Sales by Country (2017-2022)
7.1.2 Europe Seasonal Influenza Vaccines Revenue by Country (2017-2022)
7.2 Europe Seasonal Influenza Vaccines Sales by Type
7.3 Europe Seasonal Influenza Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Seasonal Influenza Vaccines by Country
8.1.1 Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Seasonal Influenza Vaccines Sales by Type
8.3 Middle East & Africa Seasonal Influenza Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccines
10.3 Manufacturing Process Analysis of Seasonal Influenza Vaccines
10.4 Industry Chain Structure of Seasonal Influenza Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Seasonal Influenza Vaccines Distributors
11.3 Seasonal Influenza Vaccines Customer
12 World Forecast Review for Seasonal Influenza Vaccines by Geographic Region
12.1 Global Seasonal Influenza Vaccines Market Size Forecast by Region
12.1.1 Global Seasonal Influenza Vaccines Forecast by Region (2023-2028)
12.1.2 Global Seasonal Influenza Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Seasonal Influenza Vaccines Forecast by Type
12.7 Global Seasonal Influenza Vaccines Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline plc
13.1.1 GlaxoSmithKline plc Company Information
13.1.2 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Offered
13.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline plc Main Business Overview
13.1.5 GlaxoSmithKline plc Latest Developments
13.2 Sinovac Biotech Ltd
13.2.1 Sinovac Biotech Ltd Company Information
13.2.2 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Offered
13.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sinovac Biotech Ltd Main Business Overview
13.2.5 Sinovac Biotech Ltd Latest Developments
13.3 Changsheng Bio-Technology
13.3.1 Changsheng Bio-Technology Company Information
13.3.2 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Offered
13.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Changsheng Bio-Technology Main Business Overview
13.3.5 Changsheng Bio-Technology Latest Developments
13.4 Ccbio SA
13.4.1 Ccbio SA Company Information
13.4.2 Ccbio SA Seasonal Influenza Vaccines Product Offered
13.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ccbio SA Main Business Overview
13.4.5 Ccbio SA Latest Developments
13.5 Aleph Biomedical
13.5.1 Aleph Biomedical Company Information
13.5.2 Aleph Biomedical Seasonal Influenza Vaccines Product Offered
13.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Aleph Biomedical Main Business Overview
13.5.5 Aleph Biomedical Latest Developments
13.6 Sanofi
13.6.1 Sanofi Company Information
13.6.2 Sanofi Seasonal Influenza Vaccines Product Offered
13.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sanofi Main Business Overview
13.6.5 Sanofi Latest Developments
13.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
13.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
13.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Offered
13.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Main Business Overview
13.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Latest Developments
13.8 Dalian Hissen Bio-pharm
13.8.1 Dalian Hissen Bio-pharm Company Information
13.8.2 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Offered
13.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Dalian Hissen Bio-pharm Main Business Overview
13.8.5 Dalian Hissen Bio-pharm Latest Developments
13.9 Abbott Laboratories
13.9.1 Abbott Laboratories Company Information
13.9.2 Abbott Laboratories Seasonal Influenza Vaccines Product Offered
13.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Abbott Laboratories Main Business Overview
13.9.5 Abbott Laboratories Latest Developments
13.10 Novartis International AG
13.10.1 Novartis International AG Company Information
13.10.2 Novartis International AG Seasonal Influenza Vaccines Product Offered
13.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis International AG Main Business Overview
13.10.5 Novartis International AG Latest Developments
14 Research Findings and Conclusion
Table 1. Seasonal Influenza Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Seasonal Influenza Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Type A (H1N1)
Table 4. Major Players of Type A (H3N2)
Table 5. Major Players of Type B
Table 6. Global Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 7. Global Seasonal Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 8. Global Seasonal Influenza Vaccines Revenue by Type (2017-2022) & ($ million)
Table 9. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2022)
Table 10. Global Seasonal Influenza Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 12. Global Seasonal Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 13. Global Seasonal Influenza Vaccines Revenue by Application (2017-2022)
Table 14. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2017-2022)
Table 15. Global Seasonal Influenza Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Seasonal Influenza Vaccines Sales by Company (2020-2022) & (K Units)
Table 17. Global Seasonal Influenza Vaccines Sales Market Share by Company (2020-2022)
Table 18. Global Seasonal Influenza Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Seasonal Influenza Vaccines Revenue Market Share by Company (2020-2022)
Table 20. Global Seasonal Influenza Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Seasonal Influenza Vaccines Producing Area Distribution and Sales Area
Table 22. Players Seasonal Influenza Vaccines Products Offered
Table 23. Seasonal Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Seasonal Influenza Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Seasonal Influenza Vaccines Sales Market Share Geographic Region (2017-2022)
Table 28. Global Seasonal Influenza Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Seasonal Influenza Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Seasonal Influenza Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Seasonal Influenza Vaccines Sales Market Share by Country/Region (2017-2022)
Table 32. Global Seasonal Influenza Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Seasonal Influenza Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 35. Americas Seasonal Influenza Vaccines Sales Market Share by Country (2017-2022)
Table 36. Americas Seasonal Influenza Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Seasonal Influenza Vaccines Revenue Market Share by Country (2017-2022)
Table 38. Americas Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 39. Americas Seasonal Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 40. Americas Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 41. Americas Seasonal Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 42. APAC Seasonal Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 43. APAC Seasonal Influenza Vaccines Sales Market Share by Region (2017-2022)
Table 44. APAC Seasonal Influenza Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Seasonal Influenza Vaccines Revenue Market Share by Region (2017-2022)
Table 46. APAC Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 47. APAC Seasonal Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 48. APAC Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 49. APAC Seasonal Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 50. Europe Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 51. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2017-2022)
Table 52. Europe Seasonal Influenza Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2017-2022)
Table 54. Europe Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. Europe Seasonal Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 56. Europe Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 57. Europe Seasonal Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Seasonal Influenza Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Seasonal Influenza Vaccines Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Seasonal Influenza Vaccines
Table 67. Key Market Challenges & Risks of Seasonal Influenza Vaccines
Table 68. Key Industry Trends of Seasonal Influenza Vaccines
Table 69. Seasonal Influenza Vaccines Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Seasonal Influenza Vaccines Distributors List
Table 72. Seasonal Influenza Vaccines Customer List
Table 73. Global Seasonal Influenza Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Seasonal Influenza Vaccines Sales Market Forecast by Region
Table 75. Global Seasonal Influenza Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Seasonal Influenza Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Seasonal Influenza Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Seasonal Influenza Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Seasonal Influenza Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Seasonal Influenza Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Seasonal Influenza Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Seasonal Influenza Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Seasonal Influenza Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Seasonal Influenza Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Seasonal Influenza Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Seasonal Influenza Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Seasonal Influenza Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 93. GlaxoSmithKline plc Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Offered
Table 95. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. GlaxoSmithKline plc Main Business
Table 97. GlaxoSmithKline plc Latest Developments
Table 98. Sinovac Biotech Ltd Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Offered
Table 100. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Sinovac Biotech Ltd Main Business
Table 102. Sinovac Biotech Ltd Latest Developments
Table 103. Changsheng Bio-Technology Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Offered
Table 105. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Changsheng Bio-Technology Main Business
Table 107. Changsheng Bio-Technology Latest Developments
Table 108. Ccbio SA Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Ccbio SA Seasonal Influenza Vaccines Product Offered
Table 110. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Ccbio SA Main Business
Table 112. Ccbio SA Latest Developments
Table 113. Aleph Biomedical Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Aleph Biomedical Seasonal Influenza Vaccines Product Offered
Table 115. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Aleph Biomedical Main Business
Table 117. Aleph Biomedical Latest Developments
Table 118. Sanofi Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi Seasonal Influenza Vaccines Product Offered
Table 120. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Sanofi Main Business
Table 122. Sanofi Latest Developments
Table 123. Jiangsu Simcere Vaxtec Bio-pharmaceutical Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Offered
Table 125. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Jiangsu Simcere Vaxtec Bio-pharmaceutical Main Business
Table 127. Jiangsu Simcere Vaxtec Bio-pharmaceutical Latest Developments
Table 128. Dalian Hissen Bio-pharm Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Offered
Table 130. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Dalian Hissen Bio-pharm Main Business
Table 132. Dalian Hissen Bio-pharm Latest Developments
Table 133. Abbott Laboratories Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Abbott Laboratories Seasonal Influenza Vaccines Product Offered
Table 135. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Abbott Laboratories Main Business
Table 137. Abbott Laboratories Latest Developments
Table 138. Novartis International AG Basic Information, Seasonal Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Novartis International AG Seasonal Influenza Vaccines Product Offered
Table 140. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 141. Novartis International AG Main Business
Table 142. Novartis International AG Latest Developments
List of Figures
Figure 1. Picture of Seasonal Influenza Vaccines
Figure 2. Seasonal Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Seasonal Influenza Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Seasonal Influenza Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Seasonal Influenza Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Type A (H1N1)
Figure 10. Product Picture of Type A (H3N2)
Figure 11. Product Picture of Type B
Figure 12. Global Seasonal Influenza Vaccines Sales Market Share by Type in 2021
Figure 13. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2022)
Figure 14. Seasonal Influenza Vaccines Consumed in Pediatrics
Figure 15. Global Seasonal Influenza Vaccines Market: Pediatrics (2017-2022) & (K Units)
Figure 16. Seasonal Influenza Vaccines Consumed in Adolescence
Figure 17. Global Seasonal Influenza Vaccines Market: Adolescence (2017-2022) & (K Units)
Figure 18. Seasonal Influenza Vaccines Consumed in Adults
Figure 19. Global Seasonal Influenza Vaccines Market: Adults (2017-2022) & (K Units)
Figure 20. Seasonal Influenza Vaccines Consumed in Elderly
Figure 21. Global Seasonal Influenza Vaccines Market: Elderly (2017-2022) & (K Units)
Figure 22. Global Seasonal Influenza Vaccines Sales Market Share by Application (2017-2022)
Figure 23. Global Seasonal Influenza Vaccines Revenue Market Share by Application in 2021
Figure 24. Seasonal Influenza Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Seasonal Influenza Vaccines Revenue Market Share by Company in 2021
Figure 26. Global Seasonal Influenza Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Seasonal Influenza Vaccines Revenue Market Share by Geographic Region in 2021
Figure 28. Global Seasonal Influenza Vaccines Sales Market Share by Region (2017-2022)
Figure 29. Global Seasonal Influenza Vaccines Revenue Market Share by Country/Region in 2021
Figure 30. Americas Seasonal Influenza Vaccines Sales 2017-2022 (K Units)
Figure 31. Americas Seasonal Influenza Vaccines Revenue 2017-2022 ($ Millions)
Figure 32. APAC Seasonal Influenza Vaccines Sales 2017-2022 (K Units)
Figure 33. APAC Seasonal Influenza Vaccines Revenue 2017-2022 ($ Millions)
Figure 34. Europe Seasonal Influenza Vaccines Sales 2017-2022 (K Units)
Figure 35. Europe Seasonal Influenza Vaccines Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Seasonal Influenza Vaccines Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Seasonal Influenza Vaccines Revenue 2017-2022 ($ Millions)
Figure 38. Americas Seasonal Influenza Vaccines Sales Market Share by Country in 2021
Figure 39. Americas Seasonal Influenza Vaccines Revenue Market Share by Country in 2021
Figure 40. United States Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Seasonal Influenza Vaccines Sales Market Share by Region in 2021
Figure 45. APAC Seasonal Influenza Vaccines Revenue Market Share by Regions in 2021
Figure 46. China Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Seasonal Influenza Vaccines Sales Market Share by Country in 2021
Figure 53. Europe Seasonal Influenza Vaccines Revenue Market Share by Country in 2021
Figure 54. Germany Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Seasonal Influenza Vaccines Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Seasonal Influenza Vaccines Revenue Market Share by Country in 2021
Figure 61. Egypt Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Seasonal Influenza Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccines in 2021
Figure 67. Manufacturing Process Analysis of Seasonal Influenza Vaccines
Figure 68. Industry Chain Structure of Seasonal Influenza Vaccines
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...